ArticleBrain imaging and behavior2026
Prediction modeling in transdiagnostic risk: results from the PROCAN study.
Article in Brain imaging and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying biomarkers for serious mental illnesses (SMI) has significant implications for early intervention and prevention. The current study uses machine learning to build a model of risk prediction and transition based on multi-modal neuroimaging, clinical, and behavioral data from youth at transdiagnostic risk. Participants aged 12-25 were recruited at two sites in Canada, and followed for 4 years. Symptom severity was measured using the Scale of Psychosis-Risk Symptoms (SOPS) and K10 Distress Scale, and a range of cognitive and behavioral measures were collected, as well as magnetic resonance imaging (MRI) data. Participants were assigned to one of 5 groups: healthy controls (HC; n = 42), familial risk (stage 0; n = 40), mild symptoms (stage 1a; n = 48), attenuated syndromes (stage 1b; n = 82), or discrete disorder (transition; n = 31). Constrained spherical deconvolution was used to generate whole brain tractography maps from diffusion MRI, which were then used to calculate connectivity matrices for graph theory analysis. Graph theory was also used to analyze correlations of functional MRI signal between pairs of brain regions. All measures were evaluated in a model to predict transition between groups. Random Forest analysis identified diffusion MRI-derived nodal metrics of betweenness centrality in the angular gyrus, inferior temporal gyrus, amygdala and calcarine fissure as potential features which can discriminate between the groups. Additionally, SOPS and K10 Distress Scales were useful behavioral predictors of transdiagnostic risk. Our findings show that combining neuroimaging with clinical characteristics may result in a promising predictive model for transdiagnostic risk and transition to SMI.
Indexed as
Identifiers
42373960What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.